IGMS
$85.66
Igm Biosciences
($1.55)
(1.78%)
IGMS
Earnings Whisper ®
N/A
2nd Quarter June 2021
Consensus:  ($1.21)
Revenue:  N/A
Thursday
Aug 5
4:05 PM ET
Score
Grade
Tweet Share Watch
Tweet Share Watch

What do you expect when IGMS reports earnings?
Beat
Meet
Miss

Where is IGMS's stock price going from here?
Up
Flat
Down
Stock chart of IGMS
Analysts
Summary of analysts' recommendations for IGMS
Score
Grade
Pivots
Resistance
-
-
-

-

Support
-
-
-
Tweet
Growth
Description
IGM Biosciences Inc. is a biotechnology company. It engages in the research and development of engineered Immunoglobulin M antibodies for the treatment of cancer patients. The company's lead product candidate is IGM-2323, a bispecific T cell engaging IgM, which are in clinical stage. IGM Biosciences Inc. is based in Mountain View, California.